Comparison of Open and Laparoscopic Distal Gastrectomy for T4a Gastric Cancer
Comparison of Laparoscopic Versus Open Distal Gastrectomy for T4a Gastric Cancer: a Prospective Randomized Control Trial
1 other identifier
interventional
240
1 country
1
Brief Summary
There are more than 75% of patients with gastric cancer who are diagnosed in advanced stage in Vietnam, most of cases in T4a. The purpose of this study is to compare the technical feasibility, early and long term outcomes of open and laparoscopic distal gastrectomy for gastric adenocarcinoma in T4A stage
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable gastric-cancer
Started Jul 2020
Longer than P75 for not_applicable gastric-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 8, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedStudy Start
First participant enrolled
July 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2028
June 15, 2025
June 1, 2025
7.9 years
May 8, 2020
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
3 year overall survival by Kaplan Mayer
The percentage of people in this study who are alive three years after surgery.
3 year after surgery
3 year relapse-free survival by Kaplan Mayer
The percentage of people in this study who are alive without recurrence three years after surgery.
3 year after surgery
Secondary Outcomes (5)
operative morbidity
30 days after surgery
operative mortality
30 days after surgery
hospital stay
30 days after surgery
operative time
intraoperative
Resected lymph nodes
intraoperative
Study Arms (2)
Open distal gastrectomy
ACTIVE COMPARATORAn incision of 15\~20 cm length is made in the abdominal midline . Standard distal gastrectomy and omentectomy will be performed with D2 lymph node dissection (around common hepatic artery, celiac artery, proximal part of splenic artery, proper hepatic artery) . As a general rule, Billroth II method was used for gastric reconstruction for most cases
Laparoscopic distal gastrectomy
EXPERIMENTAL5 trocar were used. The gastrocolic ligament was divided along the border of the transverse colon. ligating the left gastroepiploic vessels to remove group 4sb. The right gastroepiploic vein was divided and the right gastroepiploic and the inferior pyloric artery were vascularized and cut at their origin from the gastroduodenal artery, just above the pancreatic head, to dissect group 6. The dissection was continued along the hepatoduodenal ligament to removed group 5 and group 12a and along the common hepatic artery to remove group 8a and along the celiac axis to remove group 9. The left gastric vein was prepared and separately divided and then the left gastric artery was vascularized to remove group 7. The dissection was continued upward along the proximal branches of splenic vessels to remove group 11p and along the lesser curvature to remove group 1,3. As a general rule, Billroth II method was used for gastric reconstruction for most cases
Interventions
Distal gastrectomy and standard D2 lymphadenectomy
Eligibility Criteria
You may qualify if:
- Pathologic finding by gastric endoscopy: confirmed gastric adenocarcinoma
- Age: 18 - 80 year old
- Tumor located at the middle or lower third of the stomach
- Preoperative cancer stage (CT scan stage): cT4aN0M0, cT4aN1M0, cT4aN2M0, cT4aN3M0
- ASA score: ≤ 3
- Informed consent patients (explanation about our clinical trials is provided to the patients or patrons, if patient is not available)
You may not qualify if:
- Concurrent cancer or patient who was treated due to other cancer before the patient was diagnosed gastric cancer
- Had another treatment methods, such as chemotherapy, immunotherapy, or radiotherapy
- Pregnant patient
- Combined resection
- Total gastrectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Center
Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam
Related Publications (2)
Dat TQ, Thong DQ, Nguyen DT, Hai NV, Phuoc TD, Anh NVT, Bac NH, Long VD. Laparoscopic vs Open Distal Gastrectomy With D2 Lymphadenectomy for Clinical T4a Gastric Cancer: The UMC-UPPERGI-01 Randomized Clinical Trial. JAMA Surg. 2026 Jan 1;161(1):9-18. doi: 10.1001/jamasurg.2025.4929.
PMID: 41222957DERIVEDDat TQ, Thong DQ, Nguyen DT, Hai NV, Vuong NL, Bac NH, Long VD. Laparoscopic versus open distal gastrectomy with d2 lymphadenectomy in treatment of locally T4A gastric cancer: the protocol of a randomized controlled trial. BMC Surg. 2025 May 2;25(1):193. doi: 10.1186/s12893-025-02933-6.
PMID: 40316937DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Long D. Vo, PhD, MD
University Medical Center, 215 Hong Bang street, Dist. 5, HCM city, VN
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Head of GI Surgery Department
Study Record Dates
First Submitted
May 8, 2020
First Posted
May 12, 2020
Study Start
July 29, 2020
Primary Completion (Estimated)
June 30, 2028
Study Completion (Estimated)
June 30, 2028
Last Updated
June 15, 2025
Record last verified: 2025-06